Industrial Materials
Build Your Comparison
Side-by-side financial analysisStock Comparison
LZM vs LIN vs ALB vs APD
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Chemicals - Specialty
Chemicals - Specialty
LZM vs LIN vs ALB vs APD — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Industrial Materials | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $354M | $238.85B | $18.76B | $61.93B |
| Revenue (TTM) | $1M | $34.66B | $5.49B | $12.46B |
| Net Income (TTM) | $-60M | $7.13B | $-233M | $2.11B |
| Gross Margin | -51.3% | 46.0% | 18.5% | 32.0% |
| Operating Margin | -55.8% | 28.8% | 5.6% | 18.4% |
| Forward P/E | — | 29.3x | 14.0x | 21.3x |
| Total Debt | $58M | $26.99B | $3.30B | $18.41B |
| Cash & Equiv. | $20M | $5.06B | $1.62B | $1.86B |
LZM vs LIN vs ALB vs APD — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Dec 21 | Jun 26 | Return |
|---|---|---|---|
| Lifezone Metals Lim… (LZM) | 100 | 39.7 | -60.3% |
| Linde plc (LIN) | 100 | 151.1 | +51.1% |
| Albemarle Corporati… (ALB) | 100 | 72.9 | -27.1% |
| Air Products and Ch… (APD) | 100 | 92.6 | -7.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: LZM vs LIN vs ALB vs APD
Each card shows where this stock fits in a portfolio — not just who wins on paper.
LZM is the clearest fit if your priority is growth exposure.
- Rev growth 6.5%, EPS growth 71.2%, 3Y rev CAGR -28.8%
- 6.5% revenue growth vs ALB's -4.4%
LIN carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 395.7% 10Y total return vs APD's 151.1%
- Lower volatility, beta 0.19, Low D/E 67.9%, current ratio 0.88x
- 20.6% margin vs LZM's -50.0%
- Beta 0.19 vs LZM's 2.53, lower leverage
ALB is the #2 pick in this set and the best alternative if value and momentum is your priority.
- Lower P/E (14.0x vs 21.3x)
- +146.9% vs LZM's -8.2%
APD is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 43 yrs, beta 0.33, yield 2.6%
- Beta 0.33, yield 2.6%, current ratio 1.38x
- 2.6% yield, 43-year raise streak, vs LIN's 1.2%, (1 stock pays no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.5% revenue growth vs ALB's -4.4% | |
| Value | Lower P/E (14.0x vs 21.3x) | |
| Quality / Margins | 20.6% margin vs LZM's -50.0% | |
| Stability / Safety | Beta 0.19 vs LZM's 2.53, lower leverage | |
| Dividends | 2.6% yield, 43-year raise streak, vs LIN's 1.2%, (1 stock pays no dividend) | |
| Momentum (1Y) | +146.9% vs LZM's -8.2% | |
| Efficiency (ROA) | 8.3% ROA vs LZM's -36.2%, ROIC 11.3% vs -13.1% |
LZM vs LIN vs ALB vs APD — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
LZM vs LIN vs ALB vs APD — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
LIN leads in 4 of 6 categories
ALB leads 1 • APD leads 1 • LZM leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
LIN leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LIN is the larger business by revenue, generating $34.7B annually — 28937.9x LZM's $1M. LIN is the more profitable business, keeping 20.6% of every revenue dollar as net income compared to LZM's -50.0%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $1M | $34.7B | $5.5B | $12.5B |
| EBITDAEarnings before interest/tax | -$64M | $12.1B | $802M | $3.9B |
| Net IncomeAfter-tax profit | -$60M | $7.1B | -$233M | $2.1B |
| Free Cash FlowCash after capex | -$66M | $5.1B | $577M | $1.1B |
| Gross MarginGross profit ÷ Revenue | -51.3% | +46.0% | +18.5% | +32.0% |
| Operating MarginEBIT ÷ Revenue | -55.8% | +28.8% | +5.6% | +18.4% |
| Net MarginNet income ÷ Revenue | -50.0% | +20.6% | -4.2% | +16.9% |
| FCF MarginFCF ÷ Revenue | -55.3% | +14.7% | +10.5% | +8.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.1% | +8.2% | +32.7% | +8.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +56.8% | +13.4% | — | +141.1% |
Valuation Metrics
ALB leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, LIN's 20.5x EV/EBITDA is more attractive than APD's 114.2x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $354M | $238.9B | $18.8B | $61.9B |
| Enterprise ValueMkt cap + debt − cash | $392M | $260.8B | $20.4B | $78.5B |
| Trailing P/EPrice ÷ TTM EPS | -23.18x | 35.33x | -27.66x | -157.13x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 29.25x | 13.98x | 21.33x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.39x | — | — |
| EV / EBITDAEnterprise value multiple | — | 20.54x | 27.09x | 114.20x |
| Price / SalesMarket cap ÷ Revenue | 335.10x | 7.03x | 3.65x | 5.14x |
| Price / BookPrice ÷ Book value/share | 4.32x | 6.08x | 1.91x | 3.57x |
| Price / FCFMarket cap ÷ FCF | — | 46.93x | 27.09x | — |
Profitability & Efficiency
LIN leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
LIN delivers a 17.8% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $-61 for LZM. ALB carries lower financial leverage with a 0.34x debt-to-equity ratio, signaling a more conservative balance sheet compared to APD's 1.06x. On the Piotroski fundamental quality scale (0–9), LIN scores 6/9 vs APD's 2/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -60.9% | +17.8% | -2.3% | +11.9% |
| ROA (TTM)Return on assets | -36.2% | +8.3% | -1.4% | +5.1% |
| ROICReturn on invested capital | -13.1% | +11.3% | +0.6% | -2.0% |
| ROCEReturn on capital employed | -16.8% | +13.0% | +0.6% | -2.4% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 6 | 6 | 2 |
| Debt / EquityFinancial leverage | 0.80x | 0.68x | 0.34x | 1.06x |
| Net DebtTotal debt minus cash | $38M | $21.9B | $1.7B | $16.6B |
| Cash & Equiv.Liquid assets | $20M | $5.1B | $1.6B | $1.9B |
| Total DebtShort + long-term debt | $58M | $27.0B | $3.3B | $18.4B |
| Interest CoverageEBIT ÷ Interest expense | -4.30x | 34.52x | 1.59x | 12.00x |
Total Returns (Dividends Reinvested)
LIN leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LIN five years ago would be worth $18,615 today (with dividends reinvested), compared to $3,996 for LZM. Over the past 12 months, ALB leads with a +146.9% total return vs LZM's -8.2%. The 3-year compound annual growth rate (CAGR) favors LIN at 13.7% vs LZM's -28.4% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -10.0% | +20.9% | +10.8% | +12.5% |
| 1-Year ReturnPast 12 months | -8.2% | +11.3% | +146.9% | +1.1% |
| 3-Year ReturnCumulative with dividends | -63.2% | +47.2% | -25.0% | +7.3% |
| 5-Year ReturnCumulative with dividends | -60.0% | +86.1% | -2.1% | +3.9% |
| 10-Year ReturnCumulative with dividends | -60.0% | +395.7% | +122.6% | +151.1% |
| CAGR (3Y)Annualised 3-year return | -28.4% | +13.7% | -9.1% | +2.4% |
Risk & Volatility
LIN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
LIN is the less volatile stock with a 0.19 beta — it tends to amplify market swings less than LZM's 2.53 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LIN currently trades 98.6% from its 52-week high vs LZM's 61.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.57x | 0.20x | 1.69x | 0.34x |
| 52-Week HighHighest price in past year | $6.40 | $522.89 | $221.00 | $307.96 |
| 52-Week LowLowest price in past year | $3.07 | $387.78 | $55.90 | $229.11 |
| % of 52W HighCurrent price vs 52-week peak | +61.6% | +98.6% | +72.0% | +90.3% |
| RSI (14)Momentum oscillator 0–100 | 33.5 | 52.8 | 28.3 | 36.3 |
| Avg Volume (50D)Average daily shares traded | 735K | 2.0M | 2.0M | 947K |
Analyst Outlook
APD leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: LZM as "Buy", LIN as "Buy", ALB as "Hold", APD as "Buy". Consensus price targets imply 77.7% upside for LZM (target: $7) vs 9.1% for LIN (target: $562). For income investors, APD offers the higher dividend yield at 2.56% vs ALB's 1.02%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $7.00 | $562.14 | $209.75 | $325.63 |
| # AnalystsCovering analysts | 2 | 28 | 45 | 42 |
| Dividend YieldAnnual dividend ÷ price | — | +1.2% | +1.0% | +2.6% |
| Dividend StreakConsecutive years of raises | — | 34 | 32 | 43 |
| Dividend / ShareAnnual DPS | — | $6.00 | $1.62 | $7.11 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.9% | 0.0% | 0.0% |
LIN leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ALB leads in 1 (Valuation Metrics).
LZM vs LIN vs ALB vs APD: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is LZM or LIN or ALB or APD a better buy right now?
For growth investors, Lifezone Metals Limited (LZM) is the stronger pick with 652.
2% revenue growth year-over-year, versus -4. 4% for Albemarle Corporation (ALB). Linde plc (LIN) offers the better valuation at 35. 3x trailing P/E (29. 3x forward), making it the more compelling value choice. Analysts rate Lifezone Metals Limited (LZM) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — LZM or LIN or ALB or APD?
On forward P/E, Albemarle Corporation is actually cheaper at 14.
0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — LZM or LIN or ALB or APD?
Over the past 5 years, Linde plc (LIN) delivered a total return of +86.
1%, compared to -60. 0% for Lifezone Metals Limited (LZM). Over 10 years, the gap is even starker: LIN returned +402. 9% versus LZM's -60. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — LZM or LIN or ALB or APD?
By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.
20β versus Lifezone Metals Limited's 2. 57β — meaning LZM is approximately 1202% more volatile than LIN relative to the S&P 500. On balance sheet safety, Albemarle Corporation (ALB) carries a lower debt/equity ratio of 34% versus 106% for Air Products and Chemicals, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — LZM or LIN or ALB or APD?
By revenue growth (latest reported year), Lifezone Metals Limited (LZM) is pulling ahead at 652.
2% versus -4. 4% for Albemarle Corporation (ALB). On earnings-per-share growth, the picture is similar: Lifezone Metals Limited grew EPS 71. 2% year-over-year, compared to -110. 3% for Air Products and Chemicals, Inc.. Over a 3-year CAGR, LIN leads at 0. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — LZM or LIN or ALB or APD?
Linde plc (LIN) is the more profitable company, earning 20.
3% net margin versus -1289. 2% for Lifezone Metals Limited — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus -1724. 9% for LZM. At the gross margin level — before operating expenses — LIN leads at 43. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is LZM or LIN or ALB or APD more undervalued right now?
On forward earnings alone, Albemarle Corporation (ALB) trades at 14.
0x forward P/E versus 29. 3x for Linde plc — 15. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LZM: 77. 7% to $7. 00.
08Which pays a better dividend — LZM or LIN or ALB or APD?
In this comparison, APD (2.
6% yield), LIN (1. 2% yield), ALB (1. 0% yield) pay a dividend. LZM does not pay a meaningful dividend and should not be held primarily for income.
09Is LZM or LIN or ALB or APD better for a retirement portfolio?
For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
20), 1. 2% yield, +402. 9% 10Y return). Lifezone Metals Limited (LZM) carries a higher beta of 2. 57 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LIN: +402. 9%, LZM: -60. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between LZM and LIN and ALB and APD?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: LZM is a small-cap high-growth stock; LIN is a large-cap quality compounder stock; ALB is a mid-cap quality compounder stock; APD is a mid-cap quality compounder stock. LIN, ALB, APD pay a dividend while LZM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.